RNA interference: A potential novel therapeutic combating HIV-1 in the central nervous system

Archivum Immunologiae et Therapiae Experimentalis

Volumn 52, Issue 6, 2004, Pages 401-409

  Pomerantz, Roger J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

HIV 1; RNA interference; siRNA; Therapeutics

Indexed keywords

LENTIVIRUS VECTOR; SMALL INTERFERING RNA;

ANTIVIRAL ACTIVITY; CELL CULTURE; CELL FUSION; CELL POPULATION; CENTRAL NERVOUS SYSTEM; EVOLUTIONARY HOMOLOGY; GENE AMPLIFICATION; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENE TARGETING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROPATHOLOGY; NONHUMAN; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; RNA INTERFERENCE; T LYMPHOCYTE ACTIVATION; VIRUS STRAIN;

AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV-1; HUMANS; RECEPTORS, CXCR4; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 12244311916     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Abbas-Terki T., Blanco-Bose W., Deglon N., Pralong W. and Aebischer P. (2002): Lentiviral-mediated RNA interference. Hum. Gene Ther., 13, 2197-2201.
2. Adamson D. C., Dawson T. M., Zink M. C., Clements J. E. and Dawson V. L. (1996): Neurovirulent simian immunodeficiency virus infection induce neuronal, endothelial, and glial apoptosis. Mol. Med., 2, 417-428.
3. Adamson D. C., Wildemann B., Sasaki M., Glass J. D., McArthur J. C., Christov V. I., Dawson T. M. and Dawson V. L. (1996): Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science, 274, 1917-1921.
4. Adie-Biassette H., Levy Y., Colombel M., Poron F., Natchcv S., Kechane C. and Gray F. (1995): Neuronal apoptosis in HIV infection in adults. Neurobiology, 21, 218-227.
5. Aggoun-Zouaoui D., Charriaut-Marlangue C., Rivera S., Jorquera I., Ben-Ari Y. and Represa A. (1996): The HIV-1 envelope protein gp120 induces neuronal apoptosis in hippocampal slices. Clin. Neurosci. Neuropathol., 7, 433-436.
6. Amarzguioui M., Holen T., Babaie E. and Prydz H. (2003): Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res., 31, 589-595.
7. Aweeka F., Jayewardene A., Staprans S., Bellibas S. E., Kearney B., Lizak P., Novakovic-Aopian T. and Rice R. W. (1999): Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex. J. Acquir. Immune Defic. Syndr., 20, 39-43.
8. Bagasra O., Lavi E., Bobroski L., Khalili K., Pestaner J. P. and Pomerantz R. J. (1996): Cellular reservoirs of HIV-1 in the central nervous system of infected-individuals: identification by the combination of in situ PCR and immunohistochemistry. AIDS, 10, 573-586.
9. Bagetta G., Corasaniti M. T., Aloe L., Berliocchi L., Costa N., Finazzai-Agro A. and Nistico G. (1996): Intracerebral infection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat. Proc. Natl. Acad. Sci. USA, 93, 928-933.
10. Barton C. H., Biggs T. E., Mee T. R. and Mann D. A. (1996): The human immunodeficiency virus type 1 regulatory protein Tat inhibits interferon-induced iNOS activity in a murine acrophage cell-line. J. Gen. Virol., 77, 1643-1647.
11. Barton G. M. and Medzhitov R. (2002): Retroviral delivery of small interfering RNA into primary cells. Proc. Natl. Acad. Sci. USA, 99, 14943-14945.
12. Bell J. E., Busutti A., Ironside J. W., Rebus S., Donaldson Y. K., Simmonds P., Peutherer J. F. (1993): Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J. Infect. Dis., 168, 818-824.
13. Benos D. J., Han B. H., Bubien J. K., Ghosh S. K., Mashburn N. A., Chaikin M. A., Shaw G. M. and Benveniste E. N. (1994): Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc. Natl. Acad. Sci. USA, 91, 494-498.
14. Bernstein E., Caudy A. A., Hammond S. M. and Hannon G. J. (2001): Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature, 409, 363-366.
15. Bernton E. W., Bryant H. U., Decoster M. A., Orenstein, J. L. Ribas, Meltzer M. S. and Gendelman H. E. (1992): No direct neurotoxicity by HIV- J.M. 1 virions or culture fluids from HIV-1-infected T cells or monocytes. AIDS Res. Hum. Retroviruses, 8, 495-503.
16. Bertrand J. R., Pottier M., Vekris A., Opolon P., Maksimenko A. and Malvy C. (2002): Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun., 296, 1000-1004.
17. Boutla A., Delidakis C., Livadaras I., Tsagris M. and Tabler M. (2001): Short 5′-phosphorylated double-stranded RNAs induce RNA interference in Drosophila. Curr. Biol., 11, 1776-1780.
18. Boyd D. C., Turner P. C., Watkins N. J., Gerster T. and Murphy S. (1995): Functional redundancy of promoter elements ensures efficient transcription of the human 7SK gene in vivo. J. Mol. Biol., 253, 677-690.
19. Brenneman D. E., Westbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M. R. and Pert C. B. (1988): Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature, 335, 639-642.
20. Brew B. J. (2004): Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS, 18, S75-78.
21. Brummelkamp T. R., Bernards R. and Agami R. (2002): A system for stable expression of short interfering RNAs in mammalian cells. Science, 296, 550-553.
22. Calegari F., Haubensak W., Yang D., Huttner W. B. and Buchholz F. (2002): Tissue-specific RNA interference in post implantation mouse embryos with endoribonuclease-prepared short interfering RNA. Proc. Natl. Acad. Sci. USA, 99, 14236-14240.
23. Canto-Nogues C., Sanchez-Ramon S. and Munoz-Fernandez M. (2001): HIV-1-infected cortical neurons in brain autopsy from children with HIV-1 related encephalopathy. 1st IAS Conference on HIV Pathogenesis and Treatment, Buenos Aires, Argentina, July 2001, p. 263.
24. Caplen N. J., Parrish S. and Imani F., Fire A. and Morgan R. A. (2001): Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA, 98, 9742-9747.
25. Capodici J., Kariko K. and Weissman D. (2002): Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol., 169, 5196-5201.
26. Castanotto D., Li H. and Rossi J. J. (2002): Functional siRNA expression from transfected PCR products. RNA, 8, 1454-1460.
27. Cavert W., Notermans D. W., Staskus K., Wietgrefe S. W., Zupancic M., Gebhard K., Henry K., Zhang Z.-Q., Mills R., McDade H., Goudsmit J., Danner S. A. and Haase A. T. (1997): Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science, 276, 960-964.
28. Chun T.W., Carruth L., Finzi D., Shen X., DiGiuseppe J. A., Taylor H., Hermankova M., Chadwick K., Margolick J., Quinn T. C., Juo Y-H., Brookmeyer R., Zeiger M. A., Barditch-Crovo P. and Siliciano R. F. (1997): Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature, 387, 183-188.
29. Chun T. W., Stuyver L., Mizell S. B., Ehler L. A., Mican J. A., Baseler M., Lloyd A. L., Nowak M. A. and Fauci A. S. (1997): Presence of an inducible HIV-1 latent reservoir during highly active anti-retroviral therapy. Proc. Natl. Acad. Sci. USA, 94, 13193-13197.
30. Coburn G. A. and Cullen B. R. (2002): Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol., 76, 9225-9231.
31. Cogoni C. and Macino G. (1999): Homology-dependent gene silencing in plants and fungi: a number of variations on the same theme. Curr. Opin. Microbiol., 2, 657-662.
32. Connelly J. C., Kirkham L. A. and Leach D. R. (1998): The SbcCD nuclease of Escherichia coli is a structural maintenance of chromosomes (SMC) family protein that cleaves hairpin DNA. Proc. Natl. Acad. Sci. USA, 95, 7969-7974.
33. Corboy J. R., Buzy J. M., Zink M. C. and Clements J. E. (3992): Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science, 258, 1804-1808.
34. Dave R. S. and Pomerantz R. J. (2004): Antiviral effects of HIV-1-specific siRNAs against targets conserved in select neurotropic viral strains. J. Virol. (in press).
35. Dawson V. L., Dawson T. M., Uhl G. R. and Snyder S. H. (1993): Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA, 90, 3256-3259.
36. Devroe E. and Silver P. A. (2002): Retrovirus-delivered siRNA. BMC Biotechnol., 2, 15.
37. Dornadula G., Zhang H., Van Uitert B., Stern J., Livornese L. Jr., Ingerman M. J., Witek J., Kedanis R. J., Natkin J., DeSimone J. and Pomerantz R. J. (1999): Residual HIV-1 RNA in the blood plasma of patients on suppressive highly active anti-retroviral therapy (HAART). J. Am. Med. Assoc. (JAMA), 282, 1627-1632.
38. Dreyer E. V., Kaiser P. K., Offermann J. T. and Lipton S. A. (1990): HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science, 248, 364-367.
39. Eddleston M., DeLa Torre J. C., Xu J.-Y., Dorfman N., Notkins A., Zolla-Pazner S. and Oldstone M. B. A. (1993): Molecular mimicry accompanying HIV-1 infection: human monoclonal antibodies that bind to gp41 and to astrocytes. AIDS Res. Hum. Retroviruses, 9, 939-944.
40. Elbashir S. M., Harborth J., Weber K. and Tuschl T. (2002): Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods, 26, 199-213.
41. Ellis R. J., Gamst A. C., Capparelli E., Spector S. A., Hsia K., Wolfson T., Abramson I., Grant I. and McCutchan J. A. (2000): Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology, 54, 927-936.
42. Everall I. P., Luthert P. J. and Lantos P. L. (1991): Neuronal loss in the frontal cortex in HIV infection. Lancet, 337, 1119-1121.
43. Finzi D., Hermankova M., Pierson T., Carruth L. M., Buck C., Chaisson R. E., Quinn T. C., Chadwick K., Margolick J., Brookmeyer R., Gallant J., Markowitz M., Ho D. D., Richman D. D. and Siliciano R. F. (1997): Identification of a reservoir for HIV-1 in patients on highly active anti-retroviral therapy. Science, 278, 1295-1300.
44. Gabuzda D. H., Ho D. D., de la Monte S. M., Hirsch M. S., Rota T. R. and Sobel R. A. (1986): Immunohistochemical identification ot HTLV-III antigen in brains of patients with AIDS. Ann. Neurol., 20, 289-295.
45. Ge Q., McManus M. T., Nguyen T., Shen C. H., Sharp P. A., Eisen H. N. and Chen J. (2003): RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. USA, 100, 2718-2723.
46. Gelbard H. A., James H. J., Sharert L. R., Perry S. W., Saito Y., Kazee A. M., Blumberg B. M. and Epstein L. G. (1995): Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol. Appl. Neurobiol., 21, 208-217.
47. Gelbard H. A., Nottet H. S. L. M., Swindells S., Jett M., Dzenko K. A., Genis P., White R., Wang L., Choi Y.-B., Zhang D., Lipton S. A., Tourtellotte W. W., Epstein L. G. and Gendelman H. E., (1994): Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol., 68, 4628-4635.
48. Genis P., Jett M., Bernton E. W., Boyle T., Gelbard H. A., Dzenko K., Keane R. W., Resnick L., Mizrachi Y. and Volsky D. J. (1992): Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophageastroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med., 176, 1703-1718.
49. Gitlin L., Karelsky S. and Andino R. (2002): Short interfering RNA confers intracellular antiviral immunity in human cells. Nature. 418, 430-434.
50. Giulian D., Vaca K. and. Noonan C. A. (1990): Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science, 250, 1593-1596.
51. Giulian D., Wendt E., Vaca K. and Noonan C. A. (1993): The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. USA, 90, 2769-2773.
52. Gosztonyi G., Artigas J., Lamperth L. and Webster H. (1994): Human immunodeficiency virus (HIV) distribution in HIV encephalitis: study of 19 cases with combined use of in situ hybridization and immunocytochemistry. J. Neuropathol. Exp. Neurol., 53, 521-534.
53. Gray F., Chretien F., Vallat-Cecouvelaere A. V. and Scaravilli F. (2003): The changing patterns of HIV neuropathology in the HAART era. J. Neuropathol. Exp. Neurol., 62, 429-440.
54. Havlir D., Cheeseman S. H., McLaughlin M., Murphy R., Erice A., Spector S. A., Greenough T. C., Sullivan J. L., Hall D., Myers M., Lamson M. and Richman D. D. (1995): High-dose nevirapine: safety, pharmacokinetics and antiviral effects in patients with human immunodeficiency virus infection. J. Infect. Dis., 171, 537-545.
55. Hesselgesser J., Taub D., Baskar P., Greenberg M., Hoxie J., Kolson D. L. and Horuk R. (1998): Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4. Curr. Biol., 8, 595-598.
56. Hu W. Y., Myers C. P., Kilzer J. M., Pfaff S. L. and Bushman F. D. (2002): Inhibition of retroviral pathogenesis by RNA interference. Curr. Biol., 12, 1301-1311.
57. Hutvagner G. and Zamore P. D. (2002): A microRNA in a multiple-turnover RNAi enzyme complex. Science, 297, 2056-2060.
58. Jacque J. M., Triques K. and Stevenson M. (2002): Modulation of HIV-1 replication by RNA interference. Nature, 418, 435-438.
59. Ji Q. and Sun R. (2003): Inhibition of gammaherpesvirus replication by RNA interference. J. Virol., 77, 3301-3306.
60. Jiang M. and Milner J. (2002): Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene, 21, 6041-6048.
61. Jianglin H., DeCastro C. M., Vandenbark G. R., Busciglio J. and Gabuzda D. (1997): Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit proto-oncogene. Proc. Natl. Acad. Sci. USA, 94, 3954-3959.
62. Ketzler S., Weis S., Haug H. and Budka H. (1990): Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol., 80, 92-94.
63. Kolson D. L. and Pomerantz R. J. (1997): AIDS dementia and HIV-1-induced neurotoxicity: Pathogenic associations and mechanisms. J. Biomed. Sci., 3, 389-414.
64. Kong L.-Y., Wilson B. C., McMillian M. K., Bing G., Hudson P. M. and Hong J.-S. (1996): The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and pro-inflammatory cytokines in mixed glial cell cultures. Cell. Immunol., 172, 77-83.
65. Kure K., Lyman W. D., Weidenheim K. M. and Dickson D. W. (1990): Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am. J. Pathol., 136, 1085-1092.
66. Lane T. E., Buchmeier M. J., Watry D. D. and Fox H. S. (1996): Expression of inflammatory cytokines and inducible nitric oxide synthase in brains of SIV-infected rhesus monkeys: applications to HIV-induced central nervous system disease. Mol. Med., 96, 27-37.
67. Lane J. H., Tarantal A. F., Pauley D., Marthas M., Miller C. J. and Lackner A. A. (1996): Localization simian immunodeficiency virus nucleic acid and antigen in brains of fetal macaques inoculated in utero. Am. J. Pathol., 149, 1097-1104.
68. Levi G., Patrizio M., Bernardo A., Petrucci T. C. and Agresti C. (1993): Human immunodeficiency virus coat protein gp120 inhibits the a-adrenergic regulation of astroglial and microglial functions. Proc. Natl. Acad. Sci. USA, 90, 1541-1545.
69. Lewis D. L., Hagstrom J. E., Loomis A. G., Wolff J. A. and Herweijer H. (2002): Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet., 32, 107-108.
70. Li C. J., Friedman D. J., Wang C., Metelev V. and Pardee A. B. (1995): Induction of apoptosis in uninfected T-lymphocytes by HIV-1 Tat protein. Science, 268, 429-431.
71. Li H., Li W. X. and Ding S. W. (2002): Induction and suppression of RNA silencing by an animal virus. Science, 296, 1319-1321.
72. Lipton S. A. and Gendelman H. E. (1995): Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med., 14, 934-940.
73. Martinez M. A., Gutierrez A., Armand-Ugon M., Blanco J., Parera M., Gomez J., Clotet B. and Este J. A. (2002): Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS, 16, 2385-2390.
74. McDonald C. K. and Kuritzkes D. R. (1997): Human immunodeficiency virus type 1 protease inhibitors. Arch. Intern. Med., 157, 951-959.
75. Merrill J. E., Koyanagi Y., Zack J., Thomas L., Martin F. and Chen I. S. Y. (1992): Induction of interleukin-1 and tumor necrosis factor α in brain cultures by human immunodeficiency virus type 1. J. Virol., 66, 2217-2225.
76. Mintz M. (1994): Clinical comparison of adult and pediatric NeuroAIDS. Adv. Neuroimmunol., 4, 207-221.
77. Moses A. V., Bloom F. E., Pauza C. D. and Nelson J. A. (1993): Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc. Natl. Acad. Sci. USA, 90, 10474-10478.
78. Moses A. V. and Nelson J. A. (1994): HIV infection of human brain capillary endothelial cells-implications for AIDS dementia. Adv. Neuroimmunol., 4, 239-247.
79. Moses A. V., Stenglein S. G., Strussenberg J. G., Wehrly K., Chesebro B. and Nelson J. A. (1996): Sequences regulating tropism of human immunodeficiency virus type I for brain capillary endothelial cells map to a unique region on the viral genome. J. Virol., 70, 3401-3406.
80. Moses A. V., Williams S. E., Strussenberg J. G., Heneveld M. L, Ruhl R. A., Bakke A. C., Bagby G. C. and Nelson J. A. (1997): HIV-1 induction of CD40 on endothelial cells promotes the out-growth of AIDS-associated B-cell lymphomas. Nat. Med., 3, 1242-1249.
81. Mukhtar M. and Pomerantz R. J. (2000): Development of an in vitro blood:brain barrier model to study molecular neuropathogenesis and neurovirological disorders induced by HIV-1 infection. J. Hum. Virol., 3, 324-335.
82. Murray E., Rausch D., Lendvay J., Sharer L. and Eiden L. (1992): Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science, 255, 1246-1249.
83. Myslinski E., Ame J. C., Krol A. and Carbon P. (2001): An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene. Nucleic Acids Res., 29, 2502-2509.
84. Nguyen V. T., Kiss T., Michels A. A. and Bensaude O. (2001): 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature, 414, 322-325.
85. Noonberg S. B., Scott G. K. and Benz C. C. (1996): Evidence of post-transcriptional regulation of U6 small nuclear RNA. J. Biol. Chem., 271, 10477-10481.
86. Nottet H. S. L. M., Jett M., Flanagan C. R.,. Zhi Q.-H., Persidsky Y., Rizzino A., Bernton E. W., Genis P., Baldwin T., Schwartz J., LaBenz C. J. and Gendelman H. E. (1995): A regulatory of eicosanoids, platelet-activating factor, and tumor necrosis factor-α by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol., 154, 3567-3581.
87. Novina C. D., Murray M. F., Dykxhoorn D. M., Beresford P. J., Riess J., Lee S. K., Collman R. G., Lieberman J., Shankar P. and Sharp P. A. (2002): siRNA-directed inhibition of HIV-1 infection. Nat. Med., 8, 681-686.
88. Nunnari G., Otero M., Dornadula G., Vanella M., Zhang H., Frank I. and Pomerantz R. J. (2002): Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. AIDS, 16, 39-45.
89. Nuovo G. J., Gallary F., MacConnell P. and Braun A. (1994): In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system. Am. J. Pathol., 144, 659-666.
90. Olson K. E., Adelman Z. N., Travanty E. A., Sanchez-Vargas I., Beaty B. J. and Blair C. D. (2002): Developing arbovirus resistance in mosquitoes. Insect. Biochem. Molec. Biol., 32, 1333-1343.
91. Oyaizu N. and Pahwa S. (1995): Role of apoptosis in HIV disease pathogenesis. J. Clin. Immunol., 15, 217-231.
92. Pantaleo G., Graziosi C., Demarest J. F., Butini L., Montroni M., Fox C., Orenstein J., Kotler D. and Fauci A. S. (1993): HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature, 362, 355-358.
93. Perelson A. S., Essunger P., Cao Y., Vesanen M., Hurley A., Saksela K., Markowitz M. and Ho D. D. (1997): Decay characteristics of HIV-1-infected compartments during combination therapy. Nature, 387, 188-191.
94. Perelson A. S., Neumann A. U., Markowitz M., Leonard J. M. and Ho D. D. (1996): HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span and viral generation time. Science, 271, 1582-1586.
95. Petito C. K. and Roberts B. (1995): Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol., 146, 1121-1130.
96. Pialouz G., Fournier S., Moulignier A., Poveda J.-D., Clavel F. and Dupont B. (1997): Central nervous system as a sanctuary for HIV-1 infection despite treatment and zidovudine, amivudine and indinavir. AIDS, 11, 1302-1303.
97. Pomerantz R. J. (1999): Residual HIV-1 disease in the era of highly active antiretroviral therapy. N. Engl. J. Med., 340, 1672-1674.
98. Pomerantz R. J. (2002): HIV-1 reservoirs: the major obstacle to viral eradication. Clin. Infect. Dis., 34, 91-97.
99. Price R. W., Brew B., Sidtis J., Rosenblum M., Scheck A. C. and Cleary P. (1988): The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science, 239, 586-592.
100. Pulliam L., West D., Haigwood N. and Swanson R. A. (1993): HIV-1 envelope gp120 alters astrocytes in human brain cultures. AIDS Res. Hum. Retroviruses, 9, 439-444.
101. Pumarola-Sune T., Navia B. A., Cordon-Cardo C., Cho E.-S. and Price R. W. (1987): HIV antigen in the brains of patients with the AIDS dementia complex. Ann. Neurol., 21, 490-496.
102. Qin X.-F., An D. S., Chen I. S. Y. and Baltimore D. (2003): Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. USA, 100, 183-188.
103. Randall G., Grakoui A. and Rice C. M. (2003): Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl. Acad. Sci. USA, 100, 235-240.
104. Ranki A., Nyberg M., Ovod V., Haltia M., Elovaara I., Raininko R., Haapasalo H. and Krohn K. (1995): Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS, 9, 1001-1008.
105. Rausch D. M., Heyes M. P., Murray E. A., Lendvay J., Sharer L. R., Ward J. M., Rehm S., Nohr D., Weihe E. and Eiden L. E. (1994): Cytopathologic and neurochemical correlates of progression to motor/cognitive impairment in SIV-infected rhesus monkeys. J. Neuropathol. Exp. Neurol., 53, 165-175.
106. Rausch D. M., Heyes M. P., Murray A. and Eiden L. E. (1995): Zidovudine treatment prolongs survival and decreases virus load in the central nervous system of rhesus macaques infected perinatally with simian immunodeficiency virus. J. Infect. Dis., 172, 59-69.
107. Resnick L., Berger J. R., Shapshak P. and Tourtellotte W. W. (1988): Early penetration of the blood-brain-barrier by HIV. Neurology, 38, 9-14.
108. Sacktor N. C., Skolasky R. L., Lyles R. H., Esposito D., Seines O. A. and McArthur J. C. (2000): Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J. Neurovirol., 6, 84-88.
109. Saito Y., Sharer L. R., Epstein L. G., Michaels J., Mintz M., Louder M., Golding K., Cvetkovich T. A. and Blumberg B. M. (1994): Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in post-mortem pediatric central nervous tissues. Neurology, 44, 474-481.
110. Shen C., Buck A. K., Liu X., Winkler M. and Reske S. N. (2003): Gene silencing by adenovirus-delivered siRNA. FEBS Lett., 539, 111-114.
111. Shi B., DeGirolami U., He J., Wang S., Lorenzo A., Busciglio J. and Gabuzda D. (1996): Apoptosis induced by HIV-1 infection of the central nervous system. J. Clin. Invest., 98, 1979-1990.
112. Shi B., Raina J., Lorenzo A., Busciglio J. and Gabuzda D. (1998): Neuronal apoptosis induced by HIV-1 Tat protein and TNF-α potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J. Neurovirol., 4, 281-290.
113. Sijen T. and Kooter J. M. (2000): Post-transcriptiorial gene-silencing: RNAs on the attack or on the defense? Bioessays, 22, 520-531.
114. Song E., Lee S. K., Wang J., Ince N., Ouyang N., Min J., Chen J., Shankar P. and Lieberman J. (2003): RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med., 9, 347-351.
115. Sorensen D. R., Leirdal M. and Sioud M. (2003): Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol., 327, 761-766.
116. Spector S. A., Hsia K., Pratt P., Lathey J., McCutchan J. A., Alcaraz J. E., Atkinson J. H., Gulevich S., Wallace M. and Grant I. (1993): Virologie markers of human immunodeficiency virus type I in cerebrospinal fluid. J. Infect. Dis., 168, 68-74.
117. Stenglein S. G., Moses A. V. and Nelson J. A. (1997): How does HIV cause dementia? ATIN: AIDS Targeted Information. pp. 1-2.
118. Sui G., Soohoo C., Affar el B., Gay F., Shi Y., Forrester W. C. and Shi Y. (2002): A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA, 99, 5515-5520.
119. Surig D., Bredow S. and Benecke B. J. (1993): The seemingly identical 7SK and U6 core promoters depend on different transcription factor complexes. Gene Exp., 3, 175-185.
120. Tashima K. T., Caliendo A. M., Ahmad M., Gormley J. M., Fiske W. D., Brennan J. M. and Flanigan T. P. (1999): Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy. J. Infect. Dis., 180, 862-864.
121. Taylor S. and Pereria A. S. (2001): Antiretroviral drug concentrations in semen of HIV-1-infected men. Sex Transm. Infect., 77, 4-11.
122. Toggas S. M., Masliah E., Rockenstein E. M., Rali G. F., Abraham C. R. and Mucke L. (1994): Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 367, 188-194.
123. Tornatore C., Changra R., Berger J. R. and Major E. O. (1994): HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology, 44, 481-487.
124. Tozzi V., Balestra P., Galgani S., Narciso P., Ferri F., Sebastiani G., D'Amato C., Affricano C., Pigorini F., Pau F. M., DeFelici A. and Benedetto A. (1999): Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS, 13, 1889-1897.
125. Vacca J. P., Dorsey B. D., Schleif W. A., Levin R. B., McDaniel S. L., Darke P. L., Zugay J., Quintero J. C., Blahy O. M., Roth E., Sardana V. V., Schlabach A. J., Graham P. I., Condra J. H., Gottlieb L., Holloway M. K., Lin J., Chen I.-W., Vastag K., Ostovic D., Anderson P. S., Emini E. A. and Huff J. K. (1994): L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. Proc. Natl. Acad. Sci. USA, 91, 4096-4100.
126. Venkatesh L. K., Arens M. Q., Subramanian T. and Chinnadurai G. (1990): Selective induction of toxicity to human cells expressing human immunodeficiency virus type 1 Tat by a conditionally cytotoxic adenovirus vector. Proc. Natl. Acad. Sci. USA, 87, 8746-8750.
127. Vincent V. A. M., De Groot C. J. A., Lucassen P. J., Portegiesm P., Troost D., Tilders F. J. H. and Van Dam A.-M. (1999): Nitric oxide synthase expression and apoptotic cell death in brains of AIDS and AIDS dementia patients. AIDS, 13, 317-326.
128. von Giesen H.-J., Koller H., Theise A. and Arendt G. (2002): Therapeutic effects of non-nucleoside reverse transcriptase inhibitors on the central nervous system in HIV-1-infected patients. J. Acquir. Immune Defic. Syndr., 29, 363-367.
129. Wilson J. A., Jayasena S., Khvorova A., Sabatinos S., Rodrigue-Gervais I. G., Arya S., Sarangi F., Harris-Brandts M., Beaulieu S. and Richardson C. D. (2003): RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc. Natl. Acad. Sci. USA, 100, 2783-2788.
130. Wong J. K., Hezareh M., Gunthard H. F., Havlir D. V., Ignacio C. C., Spina C. A. and Richman D. D. (1997): Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science, 278, 1291-1295.
131. Wyss-Coray T., Masliah E., Toggas S. M., Rockenstein E. M, Brooker M. J., Lee H. S. and Mucke L. (1996): Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J. Clin. Invest., 97, 789-798.
132. Yu J. Y., DeRuiter S. L. and Turner D. L. (2002): RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA, 99, 6047-6052.
133. Yu J. Y., Taylor J., DeRuiter S. L., Vojtek A. B. and Turner D. L. (2003): Simultaneous inhibition of GSK3α and GSK3β using hairpin siRNA expression vectors. Mol. Ther., 7, 228-236.
134. Zhang H., Dornadula G., Beumont M., Livornese L., Van Uitert B., Henning K. and Pomerantz R. J. (1998): HIV-1 in the semen of men receiving highly active anti-retroviral therapy. N. Engl. J. Med., 339, 1803-1809.
135. Zheng J., Ghorpade A., Niemann D., Cotter R. L., Thylin M. R., Epstein L., Swartz J. M., Shepard R. B., Liu X., Nukuna A. and Gendelman H. E. (1999): Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia. J. Virol., 73, 8256-8267.
136. Zhou N., Fang J., Mukhtar M., Acheampong E. and Pomerantz R. J. (2004): Inhibition of HIV-1 fusion with small interfering RNAs (siRNAs) targeting the chemokine co-receptor, CXCR4. Gene Ther. (in press).